J&J Executive Compensation Details Revealed
Ticker: JNJ · Form: DEF 14A · Filed: Mar 12, 2025 · CIK: 200406
Sentiment: neutral
Topics: executive-compensation, proxy-statement, annual-filing
TL;DR
J&J dropped its 2024 exec pay details - equity awards, pensions, etc. are all in the filing.
AI Summary
Johnson & Johnson filed its DEF 14A on March 12, 2025, detailing executive compensation for the fiscal year ending December 29, 2024. The filing includes information on equity awards, pension values, and changes in compensation for both principal executive officers (PEO) and non-PEO named executive officers. Specific dollar amounts and dates related to these compensation components are outlined within the document.
Why It Matters
This filing provides transparency into how Johnson & Johnson compensates its top executives, which can influence investor perception and corporate governance discussions.
Risk Assessment
Risk Level: low — This is a routine annual filing disclosing executive compensation and does not present new or unexpected risks.
Key Numbers
- 2834 — SIC Code (Identifies Johnson & Johnson's industry as Pharmaceutical Preparations.)
Key Players & Entities
- JOHNSON & JOHNSON (company) — Filer
- 0000200406 (company) — Central Index Key
- 20250312 (date) — Filing Date
- 2024-12-29 (date) — Fiscal Year End
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Proxy Statement, is used by companies to solicit proxies from shareholders when seeking shareholder approval for corporate actions or to elect directors.
When was Johnson & Johnson's fiscal year end for the period covered by this filing?
The fiscal year end for the period covered by this filing was December 29, 2024.
What type of compensation details are typically found in a DEF 14A?
DEF 14A filings typically detail executive compensation, including salary, bonuses, stock awards, option awards, and other benefits, as well as information on director compensation and corporate governance matters.
What is the Central Index Key (CIK) for Johnson & Johnson?
The Central Index Key for Johnson & Johnson is 0000200406.
What is the Standard Industrial Classification (SIC) code for Johnson & Johnson?
The Standard Industrial Classification code for Johnson & Johnson is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on March 12, 2025 regarding JOHNSON & JOHNSON (JNJ).